propranolol has been researched along with flunarizine in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (17.24) | 18.7374 |
| 1990's | 7 (24.14) | 18.2507 |
| 2000's | 7 (24.14) | 29.6817 |
| 2010's | 9 (31.03) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Brouillette, WJ; Brown, GB; Zha, C | 1 |
| Arnott, WS; Gawel, MJ; Kreeft, J; Nelson, RF; Simard, D | 1 |
| Koch, G; Wessely, P; Wöber, C; Wöber-Bingöl, C | 1 |
| Lütschg, J; Vassella, F | 1 |
| Fritz, VU; Levien, SL; Shimell, CJ | 1 |
| Ludin, HP | 1 |
| Bousser, MG; Massiou, H | 1 |
| Amery, WK | 1 |
| Lücking, CH; Oestreich, W; Schmidt, R; Soyka, D | 1 |
| Henry, PD | 1 |
| Amery, WK; De Locht, P; Verspeelt, J | 2 |
| Amato, D; Bonuso, S; Caruso, G; de Angelis, S; Di Stasio, E; Marano, E; Scellini, T | 1 |
| Evers, S; Gerber, WD; Naumann, E; Pothmann, R; Uberall, M | 1 |
| De Beukelaar, F; Diener, HC; Hartung, E; Ludin, HP; Matias-Guiu, J; Nappi, G; Pfaffenrath, V | 1 |
| Armelao, L; Cristoni, S; Gross, S; Seraglia, R; Tondello, E; Traldi, P | 1 |
| Yu, L; Zeng, S | 1 |
| Cansu, A; Gulbahar, O; Hirfanoglu, T; Serdaroglu, A | 1 |
| Bermejo, PE; Dorado, R; Gomez-Arguelles, JM | 1 |
| Aydin, M; Bozdag, S; Ertugrul, S; Kabakus, N | 1 |
| García-Albea, E | 1 |
| Chronicle, EP; Linde, M; McCrory, DC; Mulleners, WM | 1 |
| Bayram, E; Hiz Kurul, S; Sozmen, K; Topcu, Y; Yis, U | 1 |
| Van de Heyning, P; Van Ombergen, A; Van Rompaey, V; Wuyts, F | 1 |
| Álvarez-Morujo de Sande, MG; Bécares-Martínez, C; Domènech-Vadillo, E; Domínguez-Durán, E; González-Aguado, R; Guerra-Jiménez, G; Montilla-Ibáñez, MA | 1 |
4 review(s) available for propranolol and flunarizine
| Article | Year |
|---|---|
Atherosclerosis, calcium, and calcium antagonists.
Topics: Animals; Aorta; Arteries; Arteriosclerosis; Calcinosis; Calcium; Calcium Channel Blockers; Cell Survival; Cholesterol, Dietary; Cinnarizine; Diltiazem; Flunarizine; Humans; Membrane Lipids; Muscle, Smooth, Vascular; Nicardipine; Nifedipine; Propranolol; Rabbits; Verapamil | 1985 |
[Treatment of idiopathic headache in childhood - recommendations of the German Migraine and Headache Society (DMKG)].
Topics: Acetaminophen; Adrenergic beta-Antagonists; Age Factors; Analgesics, Non-Narcotic; Biofeedback, Psychology; Child; Flunarizine; GABA Agents; Headache; Humans; Ibuprofen; Metoprolol; Migraine Disorders; Practice Guidelines as Topic; Propranolol; Relaxation Therapy; Serotonin Receptor Agonists; Sumatriptan; Tension-Type Headache; Valproic Acid; Vasodilator Agents | 2002 |
[Migraine associated with conversion symptoms (Babinski's migraine): evaluation of a series of 43 cases].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Conversion Disorder; Diagnostic and Statistical Manual of Mental Disorders; Electroencephalography; Family; Female; Flunarizine; Hemiplegia; Humans; Hysteria; Male; Mental Disorders; Middle Aged; Migraine Disorders; Pain Measurement; Positron-Emission Tomography; Propranolol; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.
Topics: Adult; Anticonvulsants; Flunarizine; Fructose; Humans; Migraine Disorders; Propranolol; Randomized Controlled Trials as Topic; Topiramate; Valproic Acid | 2013 |
9 trial(s) available for propranolol and flunarizine
| Article | Year |
|---|---|
Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.
Topics: Adolescent; Adult; Aged; Body Weight; Canada; Double-Blind Method; Female; Flunarizine; Hemodynamics; Humans; Male; Middle Aged; Migraine Disorders; Propranolol; Single-Blind Method | 1992 |
[The treatment of juvenile migraine using flunarizine or propranolol].
Topics: Adolescent; Child; Child, Preschool; Double-Blind Method; Female; Flunarizine; Humans; Male; Migraine Disorders; Propranolol; Surveys and Questionnaires | 1990 |
A comparative trial of flunarizine and propranolol in the prevention of migraine.
Topics: Adolescent; Adult; Double-Blind Method; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Disorders; Propranolol; Randomized Controlled Trials as Topic | 1990 |
Flunarizine and propranolol in the treatment of migraine.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Patient Dropouts; Propranolol; Random Allocation | 1989 |
Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients.
Topics: Adult; Analgesics; Double-Blind Method; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Disorders; Propranolol; Time Factors | 1988 |
Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Basal Ganglia Diseases; Belgium; Child; Cohort Studies; Depression; Fatigue; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Disorders; Netherlands; Propranolol; Prospective Studies; Risk Factors; Safety; Treatment Outcome; Vasodilator Agents; Weight Gain | 1996 |
Long-term outcome of migraine therapy: predictive value of the frontotemporal nitroglycerin test.
Topics: Adult; Female; Flunarizine; Follow-Up Studies; Humans; Male; Middle Aged; Migraine Disorders; Nitroglycerin; Propranolol; Time Factors; Treatment Outcome; Vasodilator Agents | 1998 |
Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily.
Topics: Adolescent; Adult; Aged; Chi-Square Distribution; Confidence Intervals; Double-Blind Method; Drug Administration Schedule; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Disorders; Propranolol; Statistics, Nonparametric | 2002 |
Variation in almotriptan effectiveness according to different prophylactic treatments.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anticonvulsants; Calcium Channel Blockers; Drug Interactions; Drug Therapy, Combination; Female; Flunarizine; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Propranolol; Serotonin Receptor Agonists; Topiramate; Treatment Outcome; Tryptamines; Young Adult | 2009 |
16 other study(ies) available for propranolol and flunarizine
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A highly predictive 3D-QSAR model for binding to the voltage-gated sodium channel: design of potent new ligands.
Topics: Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Voltage-Gated Sodium Channels | 2014 |
Long-term results of migraine prophylaxis with flunarizine and beta-blockers.
Topics: Adult; Aged; Female; Flunarizine; Humans; Male; Metoprolol; Middle Aged; Migraine Disorders; Prognosis; Propranolol; Time Factors | 1991 |
[Antimigrainous agents used in maintenance treatment].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Aspirin; Benzoxepins; Calcium Channel Blockers; Cinnarizine; Clonidine; Dihydroergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Pizotyline; Propranolol | 1986 |
Onset of action of various migraine prophylactics.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Disorders; Pizotyline; Propranolol; Thiophenes | 1988 |
Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine.
Topics: Basal Ganglia Diseases; Betahistine; Cohort Studies; Depression; Female; Flunarizine; Histamine H1 Antagonists; Humans; Male; Migraine Disorders; Product Surveillance, Postmarketing; Propranolol; Prospective Studies; Risk Factors; Vasodilator Agents; Vertigo | 1996 |
Matrix-assisted laser desorption/ionisation mass spectrometry in the study of polycondensation of Ti(OBun)4 in the presence of Si(OEt)4.
Topics: Algorithms; Biotransformation; Chromatography, High Pressure Liquid; Cisapride; Flunarizine; Humans; In Vitro Techniques; Mass Spectrometry; Microsomes, Liver; Pharmaceutical Preparations; Pharmacokinetics; Propranolol; Verapamil | 2003 |
Pharmacological prevention of migraine: to be considered case by case.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anticonvulsants; Antidepressive Agents; Cost-Benefit Analysis; Flunarizine; France; Humans; Methysergide; Migraine Disorders; Pizotyline; Propranolol; Serotonin Antagonists; United Kingdom; Valproic Acid | 2006 |
Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
Topics: Aspirin; Atenolol; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biological Transport; Caco-2 Cells; Cetirizine; Cimetidine; Diffusion; Dose-Response Relationship, Drug; Drug Interactions; Flunarizine; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Mucosa; Oxazolidinones; Permeability; Propranolol; Serotonin Receptor Agonists; Sodium-Hydrogen Exchangers; Tryptamines | 2007 |
Prophylactic drugs and cytokine and leptin levels in children with migraine.
Topics: Adolescent; Amitriptyline; Central Nervous System Agents; Child; Cyproheptadine; Cytokines; Female; Flunarizine; Humans; Interleukin-1beta; Interleukin-6; Leptin; Male; Migraine Disorders; Propranolol; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Profile of children with migraine.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Flunarizine; Fructose; Humans; Male; Migraine Disorders; Prevalence; Propranolol; Risk Factors; Topiramate; Turkey; Valproic Acid; Vasodilator Agents | 2010 |
The Paediatric migraine disability assessment score is a useful tool for evaluating prophylactic migraine treatment.
Topics: Adolescent; Child; Disability Evaluation; Flunarizine; Fructose; Humans; Migraine Disorders; Propranolol; Topiramate; Treatment Outcome | 2014 |
Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness.
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Dizziness; Flunarizine; Humans; Male; Middle Aged; Migraine Disorders; Otolaryngology; Photophobia; Prevalence; Propranolol; Prospective Studies; Retrospective Studies; Vertigo; Vestibule, Labyrinth | 2015 |
Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug.
Topics: Acetazolamide; Amitriptyline; Analgesics; Central Nervous System Agents; Flunarizine; Humans; Migraine Disorders; Propranolol; Prospective Studies; Topiramate; Vertigo; Vestibular Diseases | 2020 |